GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » Research & Development

Circa Group AS (OSL:CIRCA) Research & Development : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Circa Group AS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Circa Group AS's Research & Development for the three months ended in Mar. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

Circa Group AS Research & Development Historical Data

The historical data trend for Circa Group AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circa Group AS Research & Development Chart

Circa Group AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Research & Development
- - - -

Circa Group AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Circa Group AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circa Group AS  (OSL:CIRCA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Circa Group AS Research & Development Related Terms

Thank you for viewing the detailed overview of Circa Group AS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Circa Group AS (OSL:CIRCA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » Research & Development
Comparable Companies
OSL:BGBIO OSL:EXTX OSL:TRMED OSL:LYTIX OSL:ABS OSL:PCIB OSL:ABTEC OSL:SOFTX OSL:CRNA OSL:HBC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
8U5:Germany
Address
Karenslyst alle 53, Oslo, NOR, 0279
Website
https://www.circa-group.com
Circa Group AS is a biotechnology company. The company is engaged in converting waste biomass into advanced biochemical materials. Its Furacell production process takes abundant waste biomass and makes a platform molecule, levoglucosenone.

Circa Group AS (OSL:CIRCA) Headlines

No Headlines